Multimodal and three-dimensional imaging of prostate cancer

Computerized Medical Imaging and Graphics

Volumn 29, Issue 6, 2005, Pages 477-486

  Lee, Zhenghong ^a,b   Sodee, D Bruce ^a   Resnick, Martin ^a   MacLennan, Gregory T ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

3D rendering; Multimodal imaging; Prostate carcinoma; Warping registration

Indexed keywords

ANATOMIC STRUCTURE; HISTOLOGICAL EVALUATION; PROSTATE CANCER;

ANTIBODIES; DIAGNOSIS; HISTOLOGY; PATIENT TREATMENT; THREE DIMENSIONAL; TUMORS;

MEDICAL IMAGING;

ARTICLE; AUTORADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE TUMOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; VOLUMETRY;

HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; PROSTATIC NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 24344435947     PISSN: 08956111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compmedimag.2005.01.004     Document Type: Article

References (24)

1. R.T. Greenlee Cancer statistics, 2001 CA Cancer J Clin 51 1 2001 15 36
2. D.A. Silver Prostate-specific membrane antigen expression in normal and malignant human tissues Clin Cancer Res 3 1 1997 81 85
3. M.K. Haseman, N.L. Reed, and S.A. Rosenthal Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlation Clin Nucl Med 21 9 1996 704 713
4. M.A. Seltzer Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer J Urol 162 4 1999 1322 1328
5. R.J. Hamilton Using vascular structure for CT-SPECT registration in the pelvis J Nucl Med 40 2 1999 347 351
6. D.W. Townsend, and S.R. Cherry Combining anatomy and function: the path to true image fusion Eur Radiol 11 10 2001 1968 1974
7. A. Nelson Reconstruction and analysis methods for diagnostic ProstaScint image evaluation Electromedica 68 2000 45 48
8. Z. Lee Automatic registration of MR and SPECT images for treatment planning in prostate cancer Acad Radiol 10 6 2003 673 684
9. D.B. Sodee Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer. The ProstaScint Imaging Centers Urology 56 6 2000 988 993
10. M. Levoy Display of surfaces from volume data IEEE Comput Graph Appl 8 5 1988 29 37
11. Y. Sato Three-dimensional multi-scale line filter for segmentation and visualization of curvilinear structures in medical images Med Image Anal 2 2 1998 143 168
12. Y. Sato Tissue Classification based on 3D local intensity structure for volume rendering IEEE Trans Vis Comput Graph 6 2 2000 160 179
13. J.E. McNeal, and O. Haillot Patterns of spread of adenocarcinoma in the prostate as related to cancer volume Prostate 49 1 2001 48 57
14. F. Bookstein Principal warps: thin-plate splines and the decomposition of deformations IEEE Trans Pattern Anal Mach Intel 11 6 1989 567 585
15. J.K. Troyer, M.L. Beckett, and G.L. Wright Jr. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids Int J Cancer 62 5 1995 552 558
16. G.P. Murphy Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen Cancer 83 11 1998 2259 2269
17. P.M. Smith-Jones Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor J Nucl Med 44 4 2003 610 617
18. C.B. Drachenberg, O.B. Ioffe, and J.C. Papadimitriou Progressive increase of apoptosis in prostatic intraepithelial neoplasia and carcinoma: comparison between in situ end-labeling of fragmented DNA and detection by routine hematoxylin-eosin staining Arch Pathol Lab Med 121 1 1997 54 58
19. R.J. Barren III Monoclonal antibody 7E11.C5 staining of viable LNCaP cells Prostate 30 1 1997 65 68
20. J.E. Schnitzer Vascular targeting as a strategy for cancer therapy N Engl J Med 339 7 1998 472 474
21. H.F. Dvorak, J.A. Nagy, and A.M. Dvorak Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies Cancer Cells 3 3 1991 77 85
22. M.T. Ercan, and L. Kostakoglu Radiopharmaceuticals for the visualization of infectious and inflammatory lesions Curr Pharm Des 6 11 2000 1159 1177
23. M. Carroll, and K. Britton Application of combined CT/nuclear medicine statistical change detection to tumour segmentation in ProstaScint Imaging J Nucl Med 44 5 2003 2650
24. Z. Lee, and M.S. Berridge PET imaging-based evaluation of aerosol drugs and their delivery devices: nasal and pulmonary studies IEEE Trans Med Imaging 21 10 2002 1324 1331